Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
25,037,246
-
Share change
-
-3,114,545
-
Total reported value
-
$18,630,936
-
Put/Call ratio
-
0%
-
Price per share
-
$0.74
-
Number of holders
-
41
-
Value change
-
-$2,733,884
-
Number of buys
-
12
-
Number of sells
-
20
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q2 2022
As of 30 Jun 2022,
Aptose Biosciences Inc. - Common Shares was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,037,246 shares.
The largest 10 holders included
DRW Securities, LLC, Nantahala Capital Management, LLC, CARLSON CAPITAL L P, SANDERS MORRIS HARRIS LLC, MORGAN STANLEY, Sigma Planning Corp, Voss Capital, LLC, GOLDMAN SACHS GROUP INC, P.A.W. CAPITAL CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.